Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate – NDTV

Johnson & Johnson has kicked off US human safety trials for its COVID-19 vaccine.
Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as me…

Click here to view the original article.